Related Experiment Video
Updated: Jun 8, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Patients Facing Large Language Models in Oncology: A Narrative Review
Charles Raynaud1, David Wu2, Jarod Levy3
1Department of Radiation Oncology, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
Large language models (LLMs) are revolutionizing cancer care by enhancing patient education, diagnosis, and treatment monitoring. This review explores the benefits and challenges of using LLMs in oncology.
Area of Science:
- Oncology
- Artificial Intelligence
- Medical Informatics
Background:
- Large language models (LLMs) represent a significant advancement in artificial intelligence.
- Their application in healthcare is rapidly expanding, particularly in specialized fields like oncology.
- Patients increasingly seek accessible information and support throughout their cancer journey.
Purpose of the Study:
- To review the current applications of LLMs in patient care within the oncologic domain.
- To identify the potential benefits of LLM integration for cancer patients.
- To examine the ethical and regulatory considerations surrounding LLM use in oncology.
Main Methods:
- Systematic literature review of studies on LLMs in oncology.
- Analysis of current LLM applications across the patient journey (education, diagnosis, monitoring, follow-up).
- Evaluation of reported benefits, challenges, and ethical implications.
Main Results:
- LLMs are being utilized for patient education, symptom tracking, and treatment adherence support.
- Potential benefits include personalized information, improved communication, and enhanced patient engagement.
- Significant ethical considerations include data privacy, algorithmic bias, and the need for regulatory frameworks.
Conclusions:
- LLMs hold substantial promise for transforming the oncology patient experience.
- Addressing ethical and regulatory challenges is crucial for responsible and effective implementation.
- Further research is needed to optimize LLM integration into routine oncologic care.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

